Connect with us

National

Election could jeopardize Iowa marriage rights

Democrats hoping to hang onto one-seat majority in Senate

Published

on

Liz Mathis
Liz Mathis

Liz Mathis. (Courtesy Mathis campaign site)

Next week’s special election in Iowa could jeopardize the state’s same-sex marriage rights if a Republican candidate wins and overturns Democratic control of the upper chamber of the legislature.

In an election set for Tuesday, Democrat Liz Mathis, a former news anchor for an Iowa TV station, and Republican Cindy Golding, a businessperson, are competing to represent Iowa’s 18th District in the state Senate. The vacancy was created by the retirement of Democratic former State Sen. Swati Dandekar, who left the Senate for an appointment in Republican Iowa Gov. Terry Branstad’s administration.

Senate Majority Leader Michael Gronstal (D) has vowed that a state constitutional amendment overturning marriage equality — instituted in 2009 in Iowa by order of the state Supreme Court — won’t come up as long as he remains leader of the chamber. But Democrats hold a majority in the state Senate by a margin of 25-24, so a win by the Republican would make for a tie in the leadership vote and throw control of the chamber into question.

The Democratic and Republican candidates have taken opposite positions on a constitutional amendment that could overturn marriage equality in Iowa. During an interview Monday with the Cedar Rapids Editorial Board, Mathis said she supports marriage equality, while Golding called for bringing the issue to the voters.

Mathis said she agrees with the Iowa Supreme Court ruling and said she doesn’t “believe in discrimination.”

“I believe in the Iowa State Supreme Court, their unanimous ruling, appellate ruling on gay marriage,” Mathis said. “Varnum v. Brien is constitutionally sound. And I’ll just leave it at that.”

Golding, on the other hand, reiterated her belief that the “citizens of Iowa should vote on this issue.”

“I believe that once we vote on it, whether we vote it up or down, the spotlight can come off Iowa for that issue and we can focus on business, we can focus on jobs, focus on education,” Golding said. “We can focus on the things we really need to be taking our time and energy. Because nobody in our district, it was not a huge issue to either one of us as we were going around. It became an issue to us by the national media.”

Golding continued that while she doesn’t believe the ruling has “dramatically changed” Iowa, she does believe the decision has affected schools. She took issue with what she said was scholarships for LGBT students at her daughter’s high school.

“I am curious what the sexual orientation of a student should be for a scholarship in high school,” Golding said. “That troubles me.”

Asked whether there are other criteria for the scholarship, Golding replied, “Well there’s academics, but you must be a declared GLBT student in order to apply for it. That troubles me.”

The plan for Senate leadership if the election results in a tie between the number Democrats and Republicans in the chamber remains in question. During a previous tie in 2005 and 2006, Democrats and Republicans alternatively shared power in the Senate and a rule was put in place ensuring no legislation could come up without consent of both parties. But Price said Republican Leader Paul McKinley has said he won’t agree to such a rule this time around.

In February, the Iowa House passed a constitutional amendment banning same-sex marriage, or even marriage-like unions. For the measure to come to the voters, it would need to first make it through the Senate before the term of the legislature expires. The measure would then have to pass both chambers of the General Assembly again in a separate session with the same language. The soonest the constitutional amendment could come before voters is 2013.

LGBT advocates in Iowa called a Democratic win in the election crucial to preserving marriage equality in Iowa as well as preventing other conservative initiatives from moving through the legislature.

Troy Price, executive director of One Iowa, said a Republican victory could remove the last barrier in the state legislature preventing the passage of a constitutional amendment banning same-sex marriage.

“We could see this thing on the ballot in less than two years,” Price said. “For us, this election means quite a bit, and that’s why we’re working so hard to try and protect and maintain the pro-equality majority in the Senate.”

State Sen. Matt McCoy (D), the first openly gay person elected to the Iowa Legislature, said the election is “very crucial” for marriage equality and the progressive agenda.

“This is a must-win election as it relates to marriage equality,” McCoy said. “Obviously, civil rights for tens of thousands of people are at stake, and in addition to that, I think all the other right-wing social agenda issues are potentially at stake as well. So we could see a completely different agenda: less focus on education, less focus on human services, less focus on growing our economy and jobs and more focus on right-wing fringe political issues and agendas.”

According to the Daily Iowan, the district in question is about evenly split between Democrats and Republicans.

Price said he’s “cautiously optimistic” about a Democratic win.

“Things are looking up there from our perspective,” Price said. “We’ve been working really hard. We’ve been identifying new marriage supporters in the district and trying to do everything we can to get those people out to the polls.”

McCoy also expressed confidence in Mathis’ ability to win the election and said her supporters are “spending enormous amounts of money” to ensure she wins.

“We feel very confident that we have an excellent candidate who’s working very hard and is doing all of the right things at this point to ensure that we can win this election,” McCoy said. “So, we feel very comfortable that this is a seat we can win and hold.”

The election has also come to the attention of national groups — both pro-LGBT and anti-gay — working on the issue of marriage. The National Organization for Marriage, which opposes same-sex marriage, announced last month that it would conduct an independent expenditure campaign — along with the Family Leader, a local anti-gay group — to assist Golding with her campaign.

Brian Brown, NOM’s president, called the race a “pivotal election contest” in the effort to bring marriage rights for gay couples before the Iowa electorate.

“A proposed constitutional amendment on defining marriage as the union of one man and one woman enjoys broad-based, bipartisan legislative and voter support, but is being prevented from coming to the floor of the Senate by Majority Leader Mike Gronstal,” Brown said. “If Ms. Golding is successful in her election, we are hopeful that senators will finally have the opportunity to vote on the marriage amendment, and we expect it to pass handily.”

Among NOM’s efforts is the distribution of a mailer featuring pictures of both Mathis and Golding on opposite sides on the Scales of Justice. Mathis is pulling the scale down on her side. The caption below Mathis reads, “Liz Mathis supports gay marriage; No vote of the people.” The caption below Golding reads, “Cindy Golding supports traditional marriage; Will let the people vote!”

But NOM’s involvement reportedly hasn’t stopped there. Price said he’s heard anecdotally NOM is “knocking on doors” in the district and is set to hold an event on Sunday as part of a national press tour.

“We are aware that this is on their radar screen … so we’re doing everything we can to try and counteract that,” Price said.

Pro-LGBT national groups are also involved in the election on behalf of the Democratic candidate. Price said the election is “definitely on their radar” as well, but couldn’t immediately name any of the national pro-LGBT groups that are involved. The Human Rights Campaign didn’t respond to a request for comment on the election.

“This election is really a local election from our perspective, so we’ve just been working with out local partners to make sure that the voice of equality is heard,” Price said.

 

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

The White House

EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine

Trans former assistant health secretary’s name changed on official portrait

Published

on

Adm. Rachel Levine (Washington Blade photo by Michael Key)

Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.

The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.

According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.

Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.

“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.

“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”

“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”

The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.

The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.

The Washington Blade reached out to HHS, but has not received any comment.

The lawsuit and four FOIA requests are below:

Continue Reading

Popular